Social Tree Global co-founders, Max Hannah and James Saward-Anderson share their top 5 hacks for harnessing the power of social media in financial services.
Copyright 2020 – Finance News Network
Source: Finance News Network
17 Apr 2023 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the possibility of falling inflation, immigration and the tight labour market, and the outlook for the equity market.
Read More21 Sep 2023 - Alex Parks - CEO and Managing Director - Prominence Energy (ASX:PRM) is an ASX listed oil and gas exploration and development company.
Read More21 Mar 2022 - Austco Healthcare Limited (ASX:AHC) CEO Clayton Astles provides an overview of the company, discussing technology and products, supply chain management, revenue and outlook.
Read More11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More27 Jul 2022 - TerraCom Limited (ASX:TER) Managing Director Danny McCarthy discusses highlights of the company's June quarter results, the recent rains in Queensland, the mine life and run rate of the company's key asset Blair Athol and the outlook for coal.
Read More25 Nov 2019 - Lepidico (ASX:LPD) Managing Director, Joe Walsh provides an update on drill results from its recently acquired Rubicon and Helikon deposits in Namibia, L-Max Pilot Plant trial results and outlook.
Read More10 Oct 2023 - Dean Tuck - Managing Director - Dreadnought Resources (ASX:DRE) is a highly active West Australian mineral explorer focused on finding the metals needed now and in the future.
Read More08 Aug 2023 - BluGlass Limited (ASX:BLG) Non-Executive Director Jean-Michel Pelaprat shines a light on the laser industry.
Read More16 Dec 2019 - Botanix Pharmaceuticals Limited (ASX:BOT) Founder Matthew Callahan talks about the company's Phase 2 US trial results for severe acne, plans for its Phase 3 trails, including FDA input, its Phase 2 atopic dermatitis study, and what investors can expect over the next 6 months.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More
